| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.068 | 0.2 |